Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: Update from the phase I/II TRIDENT-1 trial
Benjamin Solomon, Alexander Edward Dela Cruz Drilon, Jessica J. Lin, Lyudmila A. Bazhenova, Keiko Goto, Joop de Langen and 13 more
- Rank
- 54 of 3,639
- Percentile
- top 1.5%
- Where
- Annals of Oncology, 2023
- Citations
- 67
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.